cprice-sewell on DSK2BSOYB1PROD with NOTICES

44846 Federal Register / Vol. 74, No. 167 / Monday, August 31, 2009 / Notices 

site (http://ntp.niehs.nih.gov/go/29679). 

Comments on the draft background 

document should be sent to Dr. Ruth M. 

Lunn, NIEHS, P.O. Box 12233, MD K2– 

14, Research Triangle Park, NC 27709, 

FAX: (919) 541–0144, or 

lunn@niehs.nih.gov. Courier address: 

Report on Carcinogens Center, 530 

Davis Drive, Room 2006, Morrisville, 

NC 27560. Persons needing interpreting 

services in order to attend should 

contact (301) 402–8180 (voice) or (301) 

435–1908 (TTY). Requests should be 

made at least seven business days in 

advance of the meeting. 

FOR FURTHER INFORMATION CONTACT: Dr. 

Ruth M. Lunn, Director, RoC Center, 

(919) 316–4637, lunn@niehs.nih.gov. 

SUPPLEMENTARY INFORMATION: 

Background 

The NTP announced the RoC review 

process for the 12th RoC on April 16, 

2007, in the Federal Register (72 FR 

18999, available at http:// 

ntp.niehs.nih.gov/go/15208). As part of 

that process, an expert panel meeting is 

being convened on November 2–4, 2009, 

to review formaldehyde for possible 

listing in the 12th RoC. The draft 

background document for formaldehyde 

will be available on the RoC Web site by 

September 3, 2009, or in printed text 

from the RoC Center (see ADDRESSES 

above). Persons can register free-ofcharge with the NTP listserv (http:// 

ntp.niehs.nih.gov/go/231) to receive 

notification when draft RoC background 

documents for candidate substances and 

meetings related to the 12th RoC are 

made available on the RoC Web site. 

Formaldehyde is a high production 

chemical with a wide array of uses. The 

predominant use of formaldehyde in the 

United States is in the production of 

industrial resins (mainly urea, phenol, 

polyacetal, and melamine resins) that 

are used primarily to manufacture 

products such as adhesives and binders 

for wood products. Other uses include 

as a chemical intermediate, in 

agriculture (for example as a fumigant), 

in the production of paraformaldehyde 

and chelating agents, embalming and 

fixative or preservative in the medical 

and research fields, and as a 

preservative in numerous consumer 

products such as cleaning agents and 

cosmetic products. Formaldehyde has 

been detected in indoor and outdoor air, 

surface water and groundwater, soil, 

and food products and is generally 

considered to be ubiquitous in the 

environment. Formaldehyde (gas) is 

currently listed in the 11th RoC as 

reasonably anticipated to be a human 

carcinogen and was nominated for 

reclassification of its listing status in the 

12th RoC. 

Preliminary Agenda and Registration 

Preliminary agenda topics include: 

• Oral public comments on 

formaldehyde; 

• Peer review of the draft background 

document on formaldehyde; 

• Recommendation on the listing 

status of formaldehyde in the 12th RoC 

and scientific justification. 

The meeting is scheduled for 

November 2–4, 2009, from 8:30 a.m. to 

adjournment each day. It is anticipated 

that the meeting will adjourn by 4 p.m. 

on November 4, although adjournment 

may occur earlier or later depending 

upon the time needed for the expert 

panel to complete its work. A copy of 

the preliminary agenda, expert panel 

roster, and any additional information, 

when available, will be posted on the 

RoC Web site or may be requested from 

the Director of the RoC Center (see 

ADDRESSES above). Individuals who 

plan to attend the meeting are 

encouraged to register on-line by 

October 26, 2009, to facilitate planning 

for the meeting. 

Request for Comments 

The NTP invites both written and oral 

public comments on the draft 

background document on formaldehyde. 

Persons submitting written comments 

are asked to include their name and 

contact information (affiliation, mailing 

address, telephone and facsimile 

numbers, e-mail, and sponsoring 

organization, if any) and send them to 

Dr. Lunn (see ADDRESSES above) for 

receipt by October 16, 2009. All written 

comments identified by the individual’s 

name and affiliation or sponsoring 

organization (if applicable) will be 

posted on the RoC Web site prior to the 

meeting and distributed to the expert 

panel and RoC staff for their 

consideration in the peer review of the 

draft background document and/or 

preparation for the meeting. 

Time will be set aside at the expert 

panel meeting for the presentation of 

oral public comments. Seven minutes 

will be available for each speaker (one 

speaker per organization). Persons can 

register on-line to present oral 

comments or by contacting Dr. Lunn 

(see ADDRESSES above). When 

registering to comment orally, please 

provide your name, affiliation, mailing 

address, telephone number, e-mail and 

sponsoring organization (if any). If 

possible, send a copy of the statement 

or talking points to Dr. Lunn by October 

26, 2009. This statement will be 

provided to the expert panel to assist 

them in identifying issues for discussion 

and will be noted in the meeting record. 

Registration for presentation of oral 

comments will also be available at the 

meeting on November 2–4, 2009, from 

7:30–8:30 a.m. Time allowed for 

comments by on-site registrants may be 

less than for pre-registered speakers and 

will be determined by the number of 

persons who register at the meeting to 

give oral comments. Persons registering 

at the meeting are asked to bring 25 

copies of their statement or talking 

points for distribution to the expert 

panel and for the record. 

Background Information on the RoC 

The RoC is a congressionally 

mandated document [Section 301(b)(4) 

of the Public Health Services Act, 42 

U.S.C. 241(b)(4)], that identifies and 

discusses agents, substances, mixtures, 

or exposure circumstances (collectively 

referred to as ‘‘substances’’) that may 

pose a hazard to human health by virtue 

of their carcinogenicity. Substances are 

listed in the report as either known or 

reasonably anticipated to be human 

carcinogens. The NTP prepares the RoC 

on behalf of the Secretary of Health and 

Human Services. Information about the 

RoC and the nomination process can be 

obtained from its homepage (http:// 

ntp.niehs.nih.gov/go/roc) or by 

contacting Dr. Lunn (see For Further 

Information Contact above). The NTP 

follows a formal, multi-step process for 

review and evaluation of selected 

substances. The formal evaluation 

process is available on the RoC Web site 

(http://ntp.niehs.nih.gov/go/15208) or in 

printed copy from the RoC Center. 

Dated: August 21, 2009. 

John R. Bucher, 

Associate Director, National Toxicology 

Program. 

[FR Doc. E9–20878 Filed 8–28–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institute for Occupational 

Safety and Health 

Decision To Evaluate a Petition To 

Designate a Class of Employees for 

the Metals and Controls Corporation in 

Attleboro, MA, To Be Included in the 

Special Exposure Cohort 

AGENCY: National Institute for 

Occupational Safety and Health 

(NIOSH), Department of Health and 

Human Services (HHS). 

ACTION: Notice. 

SUMMARY: HHS gives notice as required 

by 42 CFR 83.12(e) of a decision to 

cprice-sewell on DSK2BSOYB1PROD with NOTICES

Federal Register / Vol. 74, No. 167 / Monday, August 31, 2009 / Notices 44847 

evaluate a petition to designate a class 

of employees for the Metals and 

Controls Corporation in Attleboro, 

Massachusetts, to be included in the 

Special Exposure Cohort under the 

Energy Employees Occupational Illness 

Compensation Program Act of 2000. The 

initial proposed definition for the class 

being evaluated, subject to revision as 

warranted by the evaluation, is as 

follows: 

Facility: Metals and Controls 

Corporation. 

Location: Attleboro, Massachusetts. 

Job Titles and/or Job Duties: All 

Atomic Weapons Employer employees 

who were exposed to thorium. 

Period of Employment: January 1, 

1952 through December 31, 1967. 

FOR FURTHER INFORMATION CONTACT: 

Larry Elliott, Director, Office of 

Compensation Analysis and Support, 

National Institute for Occupational 

Safety and Health (NIOSH), 4676 

Columbia Parkway, MS C–46, 

Cincinnati, OH 45226, Telephone 513– 

533–6800 (this is not a toll-free 

number). Information requests can also 

be submitted by e-mail to 

OCAS@CDC.GOV. 

Christine M. Branche, 

Acting Director, National Institute for 

Occupational Safety and Health. 

[FR Doc. E9–20899 Filed 8–28–09; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Office of Research Integrity; Privacy 

Act of 1974; Report of an Altered 

System of Records 

AGENCY: Office of Research Integrity 

(ORI), Office of Public Health and 

Science (OPHS), Office of the Secretary 

(OS), Department of Health and Human 

Services (HHS). 

ACTION: Notice of revision to the Privacy 

Act system of records. 

SUMMARY: HHS proposes to revise the 

Privacy Act exempt system of records 

09–37–0021, entitled ‘‘Public Health 

Service Records Related to Inquiries and 

Investigations of Scientific Misconduct, 

HHS/OASH/ORI.’’ This system became 

effective on August 29, 1994 (59 FR 

36717, July 19, 1994). Changes were 

made in response to comments received, 

and the revised systems notice was 

published on January 6, 1995 (60 FR 

2140). The proposed revisions include 

changing the routine uses and changing 

the title of the system to ‘‘HHS Records 

Related to Research Misconduct 

Proceedings, HHS/OS/ORI.’’ The 

revisions are necessary to reflect the 

changes made by the Public Health 

Service Policies on Research 

Misconduct (‘‘PHS Policies on Research 

Misconduct’’), 42 CFR Part 93 (‘‘Part 

93’’), and to update the system to reflect 

current practices and procedures under 

that regulation. 

DATES: This notice will be effective 

without further notice on September 30, 

2009 unless modified by a subsequent 

notice making changes in response to 

public comments. Although the Privacy 

Act requires only that changes in the 

routine uses be published for comment, 

HHS invites comments on all parts of 

the systems notice. You may submit 

comments by electronic mail to 

AskORI@hhs.gov. Comments must be 

received on or before September 30, 

2009. 

FOR FURTHER INFORMATION CONTACT: 

Director, Division of Investigative 

Oversight, Office of Research Integrity, 

1101 Wootton Parkway, Suite 750, 

Rockville, MD 20852. (240) 453–8800. 

E-mail: AskORI@hhs.gov. 

SUPPLEMENTARY INFORMATION: After 

making changes in response to public 

comments, ORI published its current 

systems notice entitled ‘‘Public Health 

Service Records Related to Inquiries and 

Investigations of Scientific Misconduct, 

HHS/OASH/ORI’’ on January 6, 1995 

(60 FR 2140). Since that time, the 

organizational location of ORI has 

changed from the former Office of the 

Assistant Secretary for Health to OPHS, 

and a new HHS regulation concerning 

research misconduct was promulgated 

and codified at 42 CFR Part 93. That 

regulation substantially changed the 

previous regulation on scientific 

misconduct (42 CFR Part 50, Subpart A), 

including changing the term 

‘‘misconduct in science’’ to ‘‘research 

misconduct.’’ 

This revision updates the ORI system 

notice to be consistent with the 

definitions and procedures promulgated 

by the PHS Policies on Research 

Misconduct. The description of the 

categories of individuals covered by the 

records system and categories of records 

in the system have been amended to 

reflect the changes made by Part 93, 

specifically, the applicability of that 

part in terms of the individuals, types of 

research, and types of PHS support that 

are covered. Pertinent provisions of Part 

93 are referenced to explain the records 

system coverage. The category of 

individuals covered by the system 

remains the same: individuals who are 

the subject of allegations of research 

misconduct. Similarly, the categories of 

records in the system remain essentially 

the same: records related to all stages of 

the research misconduct proceeding. 

The location of the system is now 

limited to the premises of ORI and the 

Federal Records Centers (for inactive 

records). PHS officials outside of ORI 

who are involved in extramural and 

intramural research misconduct 

proceedings have access to this system 

of records as necessary to carry out their 

duties. 

We have amended the statement of 

purposes to state more generally that 

ORI will use the system of records to 

exercise its oversight authority relating 

to research misconduct proceedings, 

and to document these activities. 

The order of the routine uses has been 

changed, and the terminology used has 

been updated to reflect the terms used 

in Part 93. The listing of routine uses 

begins with disclosures that may be 

made in the course of a research 

misconduct proceeding in roughly the 

order that they might occur, and ends 

with disclosures that may be necessary 

for more general administrative 

purposes. 

Routine use 1 is an expanded version 

of routine uses 2 and 5 in the current 

system notice. It now provides for 

disclosure to a person able to ‘‘obtain’’ 

information, as well as provide 

information or assistance, in a research 

misconduct proceeding or related 

proceeding, ORI oversight of an 

institutional research misconduct 

proceeding or ORI oversight of the 

implementation of HHS administrative 

actions. The reference to ORI oversight 

functions has also been added. We have 

also added a condition for each 

disclosure under this routine use. Prior 

to disclosure, ORI will determine 

whether limited disclosures or 

confidentiality agreements are needed to 

protect the privacy of respondent(s), 

complainant(s), witnesses, research 

subjects or others who may be identified 

in the records to be disclosed. 

Routine use 2 is new. It is based on 

42 CFR 93.401 that, in part, authorizes 

ORI to notify and consult with other 

Federal, State, or local offices, if ORI has 

reason to believe that a research 

misconduct proceeding may involve 

that office. The second routine use in 

the current system notice, relating to 

disclosures to qualified experts, has 

been deleted because that disclosure is 

now covered by the more general 

disclosure in the new routine uses 1 and 

9. 

Except for editorial changes, routine 

use 3 is the same as use 8 in the current 

system notice and routine use 4 is the 

same as use 3 in the current notice. 

Routine use 5 is new. It permits 

additional disclosures after a final HHS/ 

ORI finding of research misconduct that 

are aimed at conserving public funds,